Replies to post #225843 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

I doubt it. Missling relayed same in the cc.

Running extensions is considerably cheaper in Australia. The extension data along with the paediatric trial also in Australia makes sense for TGA approval discussions.